KMS Medisurgi Ltd.
Snapshot View

34.00 ▼0%

19 May 2021, 04:00:00 P.M.

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.kmsgroup.in
Financial Indicators
Market Cap 11.22 Cr.
Earnings per share (EPS) 0.48 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 71.01 Trailing Twelve Months Ending 2021-03
Industry PE - Trailing Twelve Months Ending 2021-03
Book Value / Share 19.23 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.77 Calculated using Price: 34.00
Dividend Yield 0.15 Period Ending 2020-03
No. of Shares Subscribed 0.33 Cr. 3,300,000 Shares
FaceValue 10
Company Profile

The Company was originally incorporated as ‘KMS Medisurgi Private Limited’ in Mumbai, Maharashtra under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated 25th March, 1999 issued by the Registrar of Companies, Mumbai, Maharashtra. The Company was converted in to a Public Limited Company and consequently the name was changed to ‘KMS Medisurgi Limited’ vide fresh Certificate of Incorporation dated 15th June, 2016 issued by the Registrar of Companies, Mumbai, Maharashtra. They have been established in 1999 as surgical equipment company and since then they have been successfully launching new concepts through which have helped the Indian Healthcare industry. They bridge the gap between the world technological advancements and Indian Healthcare industry. They are government approved suppliers throughout India. 

Business area of the company

They manufacture and undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. They are engaged into the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy equipments, Blood Banking Equipments and other such Surgical Equipments in India. They also undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, taffeta silk fabrics with adhesive. They offer a gamut of products, which includes Absorbable Gelatin Surgical Sponge, Surgipore Tape, Surgipore Tape (Silk), Cushions for ESWL-VI Shock Wave Hand, Dressing Post-Op Medicated, Dresiing Silicon Gel, Micrporus Surgical Foam Tape, Fleece Fabric, and Double Side Adhesive tapes.

Major Events and Milestones:

  • March, 1999: Incorporation of the Company in the name and style of ‘KMS Medisurgi Private Limited’. 
  • June, 2016:  The Company was converted in to a Public Limited Company and consequently the name was changed to ‘KMS Medisurgi Limited’. 

Delivery View Details

Delivered Qty
Traded Qty

No Deliveries found

Performance View Details

1 Day
1 Week
1 Month
3 Month
-0.29%
6 Month
1 Year
+3.03%
2 Year
+12.77%
5 Year
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 9.86 4.90 2.45 2.82 6.13 6.26 1.98 1.99 1.78
Return on Capital Employed (%) 10.18 5.36 6.43 7.69 11.39 10.63 5.20 3.86 3.42
Return on Assets (%) 2.83 1.26 0.46 0.44 1.79 2.57 1.02 1.19 1.14

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 1 1 1 1 3 4 6 6 6
Non Curr. Liab. 2 2 2 2 1 1 1 1 1
Curr. Liab. 1 1 4 4 4 4 3 3 2
Minority Int.
Equity & Liab. 4 5 7 7 8 9 10 11 9
Non Curr. Assets 1 2 3 2 2 3 2 2 2
Curr. Assets 2 3 4 5 6 6 8 8 7
Misc. Exp. not W/O
Total Assets 4 5 7 7 8 9 10 11 9

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 4 6 8 9 8 8 7 10 10
Other Income 0 0 0 0 0 0 0 0
Total Income 4 6 8 9 8 8 8 10 10
Total Expenditure -3 -6 -7 -8 -8 -7 -7 -10 -10
PBIDT 0 0 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 0 1 -2 1 -1
Cash Fr. Inv. 0 -1 -2 0 0 -1 0 0 0
Cash Fr. Finan. 1 1 2 -1 1 0 2 -1 0
Net Change 0 0 0 0 1 0 0 0 -1
Cash & Cash Eqvt 0 0 0 0 1 1 2 1 0

Shareholding Pattern View Details

9 Qtrs 2018-09 (%) 2019-03 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%)
Promoter 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42
Public 25.58 25.58 25.58 25.58 25.58 25.58 25.58 25.58 25.58
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 19 Jul 2021
Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation about resignation and appointment of Managing Directors pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 SEBI (LODR).
Mon, 19 Jul 2021
Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 Intimation for Resignation of Managing Director.
Fri, 09 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- MARIAM BAHNAN
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details

No Scans Found

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 185,708.53 774.00 +10.1%
Divi's Laboratories Ltd. 129,702.64 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. 78,400.54 4,712.70 +0.9%
Cipla Ltd. 74,235.31 920.30 +4.3%
Cadila Healthcare Ltd. 59,986.20 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. 57,873.32 4,025.00 -0.3%
Aurobindo Pharma Ltd. 53,701.27 916.50 +0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 63.95 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2021-03 65.36 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.13 4,712.70 +0.9%
Cipla Ltd. Consolidated 2021-03 30.87 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 28.12 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 384.90 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.07 916.50 +0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.00 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2021-03 13.95 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.39 4,712.70 +0.9%
Cipla Ltd. Consolidated 2021-03 4.05 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 4.62 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.60 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.45 916.50 +0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 0.18 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 916.50 +0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 10.09 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 916.50 +0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 12.53 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 916.50 +0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 17,131.99 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 916.50 +0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 774.00 +10.1%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,885.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,712.70 +0.9%
Cipla Ltd. Consolidated 2020-03 1,546.98 920.30 +4.3%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 585.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,025.00 -0.3%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 916.50 +0.9%